IQVIA Holdings Inc. (IQV) stock
IQVNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 9/3016% above fair value
$257.60−7.13 (-2.69%)
Close on Nov 17, 2026Market cap $42.45BP/E 31.3Yield –
Iqvia enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Iqvia's enterprise value was $59.24B on Nov 11, 2026, against $52.28B a year earlier. Over the last 5 years it ranged from $36.89B to $64.51B, with a median of $51.37B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $59.24B | +15.0% |
| 2025 | Dec 31, 2025 | $51.50B | +8.5% |
| 2024 | Dec 31, 2024 | $47.49B | -12.9% |
| 2023 | Dec 29, 2023 | $54.53B | +11.0% |
| 2022 | Dec 30, 2022 | $49.10B | -23.9% |
| 2021 | Dec 31, 2021 | $64.51B | +42.1% |
| 2020 | Dec 31, 2020 | $45.40B | +8.1% |
| 2019 | Dec 31, 2019 | $41.99B | +21.8% |
| 2018 | Dec 31, 2018 | $34.46B | +9.9% |
| 2017 | Dec 29, 2017 | $31.37B | +198.8% |
| 2016 | Dec 30, 2016 | $10.50B | +4.2% |
| 2015 | Dec 31, 2015 | $10.07B | +13.0% |
| 2014 | Dec 31, 2014 | $8.92B | +20.3% |
| 2013 | Dec 31, 2013 | $7.41B | – |
See a number that looks wrong?